News

GraniteShares YieldBOOST ETFs Weekly Distributions Detailed Update

GraniteShares YieldBOOST ETFs Weekly Distributions Detailed Update

GraniteShares YieldBOOST ETFs Distributions Announcement

GraniteShares is excited to inform investors about the latest weekly distributions for its popular YieldBOOST ETFs, which include NVYY, TQQY, TSYY, XBTY, and YSPY. These funds provide investors the opportunity to generate income with a specific focus on innovative strategies to enhance returns. In this article, we’ll break down the distribution details and share insights on each of these unique ETFs.

Understanding the YieldBOOST ETFs

At the core of the GraniteShares strategy is the YieldBOOST approach, which seeks to provide attractive income through the systematic option selling of put options on the underlying stocks. This strategy can generate attractive premiums, helping to maximize income for investors, although it does come with certain risks. The flexibility offered by these ETFs makes them appealing to a diverse group of investors looking for income in today’s market.

Overview of Each ETF

Let’s examine the specifics of the YieldBOOST ETFs and their respective distributions:

GraniteShares YieldBOOST NVDA ETF (NVYY)

The GraniteShares YieldBOOST NVDA ETF focuses on NVIDIA Corporation stock. This fund aims to capitalize on NVIDIA’s growth while providing a distribution of $0.5172 per share on a weekly basis. With a robust distribution frequency, it allows investors to benefit from consistent income payouts.

GraniteShares YieldBOOST QQQ ETF (TQQY)

The YieldBOOST QQQ ETF is designed around the Nasdaq-100 Index, which gives investors exposure to large, innovative technology companies. This fund offers a weekly distribution of $0.1834 per share, helping investors to accumulate income from high-growth stocks in the tech sector.

GraniteShares YieldBOOST TSLA ETF (TSYY)

For Tesla enthusiasts, the TSYY ETF is a compelling choice. It provides exposure to Tesla's stock, delivering a weekly distribution of $0.2572 per share. Investors in TSYY can enjoy a combination of growth potential and regular income.

GraniteShares YieldBOOST Bitcoin ETF (XBTY)

The YieldBOOST Bitcoin ETF is tailored for those interested in cryptocurrency investments. With a distribution of $0.4782 per share, this ETF allows investors to gain exposure to Bitcoin while receiving weekly income, blending traditional yield strategies with the dynamic cryptocurrency market.

GraniteShares YieldBOOST SPY ETF (YSPY)

Lastly, the YSPY ETF rounds out the offering by providing access to the Standard & Poor's 500 Index. With a weekly distribution of $0.1938 per share, this ETF combines the stability of large-cap U.S. equities with the potential for income growth.

Distribution Details and Performance Insights

The upcoming distribution dates and the corresponding record dates for these ETFs are vital for investors to know. Distributions are set to occur on a weekly basis, providing a reliable income stream. For the mentioned ETFs, the ex-date for the next round of distributions is slated for July 18, 2025. The record dates, on which investors must hold their shares to receive these distributions, will be July 22, 2025.

GraniteShares Commitment to Investors

GraniteShares Advisors is committed to enhancing the earnings potential of these funds by organically managing the expenses associated with them. They have established a contractual arrangement that caps the total annual operating expenses at 1.15%, ensuring that more of investors' returns are retained within the funds.

Frequently Asked Questions

What are the recent distribution amounts for the YieldBOOST ETFs?

The recent distributions for the GraniteShares YieldBOOST ETFs include NVYY at $0.5172, TQQY at $0.1834, TSYY at $0.2572, XBTY at $0.4782, and YSPY at $0.1938 per share.

How does the YieldBOOST strategy work?

The YieldBOOST strategy involves selling put options on underlying stocks to generate income, contributing to potentially attractive yields for investors.

When will the next distribution occur?

The next distribution for these ETFs is scheduled for July 18, 2025, with the record date on July 22, 2025.

How are these funds managed?

GraniteShares Advisors LLC ensures efficient management by limiting the total annual operating expenses to 1.15%, which helps improve investor returns.

What should investors consider before investing in these ETFs?

Investors should thoroughly evaluate their investment objectives and the risks associated with each ETF, including specific factors like market volatility and potential loss of principal.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ABnet Touts Anthropic's AI in Corporate Evolution

Updated Category News Views 7

Changing the AI Game in Enterprise At the heart of Tel Aviv-Yafo, ABnet Communication Ltd. is spitting fire, and this ain't your average tech chatter. They're drilling right down to the marrow, stressing just how much Anthropic—kingpin of advanced AI for enterprises—is shaking up the corporate shell game. Today’s conversation leans heavily into autonomous AI, and...

Continue Reading
Matchi Debuts Protein-Packed Matcha Lattes in Cans

Updated Category News Views 3

A New Twist on Protein Beverages Today, Matchi Global LLC is rolling out something new and bold: canned protein matcha lattes. It's not just another protein shake disguised in green robes. Oh no, this is a straight-up attempt to mesh pure ceremonial-grade matcha with a full 20 grams of complete filtered milk protein. And they’re delivering it all without any of those...

Continue Reading
Dr. Sarah Leary Leads CBTN's Growth in Pediatric Oncology

Updated Category News Views 3

Pioneering Leadership for Children's Brain Tumor Network In a world where every advance in pediatric oncology can make a measurable difference, the Children's Brain Tumor Network (CBTN) has just unveiled quite the ace up its sleeve: Dr. Sarah Leary. She's stepping in as Co-Chair of its Executive Board, taking the reins alongside Brian Rood, MD. With extensive experience...

Continue Reading
TerraMaster 725 NAS Unveils AI-Era Storage Solutions

Updated Category News Views 3

Tech Giants and Pioneers Rejoice Strap in, because TerraMaster just waved the green flag on their brand-new 725 Series Xeon Rackmount NAS, and it's high time the data storage world got a shake-up. Picture this: we're in the throes of an AI boom, and companies have data needs that gobble up yesterday's solutions with the hunger of a black hole. Well, enter TerraMaster's...

Continue Reading
ScriptSafe Revolutionizes Pharmacy Payment & Ad Certification

Updated Category News Views 2

Pharmacy Certification Made Easy When ScriptSafe rolled out its certification service for pharmacies, it felt like the industry's straitjacket was finally coming off. We’re talking about a process that traditionally took months, cost a small fortune, and made pharmacies fill out forms like they were honing a doctoral thesis. But now, you've got ScriptSafe offering a...

Continue Reading
ViewScan Unveils New AI Solution and Enhanced Site

Updated Category News Views 3

ViewScan's Latest Step in AI-Powered Monitoring Long Island's own ViewScan just kicked up some dust in the AI-based monitoring scene. This outfit is rolling out a new release of its ViewScan Protect software, fortified with advanced analytics aimed at beefing up security and operational efficiency. Now, before you gloss over this news as just another tech update, let me...

Continue Reading
Handshake Introduces AI Skills Studio at NYSE Event

Updated Category News Views 5

Shaking Up the Job Market with AI Skills What's shaking things up this time around? Handshake's dramatic unveiling of its AI Skills Studio, that's what. While the world spins on its financial axis, Handshake's showing up with a toolkit that's not just geeky gobbledygook. They're dead set on prepping job seekers with the nitty-gritty of AI know-how hosted in a rather...

Continue Reading
GRAI's Innovative Play with Hangout FM in Streaming

Updated Category News Views 4

Reimagining Streaming: GRAI Buys Hangout FM The music streaming game has just been dealt a fresh hand. GRAI, an AI-driven music company, has snatched up Hangout FM, looking to ignite a social revolution in how we experience music. Sitting here, I'm thinking about all those playlists we've built but never truly shared. This acquisition might just change that by combining...

Continue Reading
FBI Vet Marcus Thomas Joins Re-fined Nonprofit Board

Updated Category News Views 3

Remember the days when the FBI felt like a mythical fortress of surveillance and high-tech wizardry? Today, we're seeing one of its key veterans, Marcus Thomas, take a different path—a path that's as gritty and necessary as any Wall Street hustle. He's jumping onto the board of Re-fined, a Denver nonprofit aiming to give survivors of sexual exploitation and human...

Continue Reading
Gun Violence Expo Aims for National Impact in Chicago

Updated Category News Views 4

Converging Minds at the Chicago Gun Violence Expo In a city known for its resilience amid diverse challenges, the National Gun Violence Prevention Expo is stepping into the spotlight. With all eyes on Chicago from September 24 to 26, this isn't just another event—it’s a clarion call for action. Uniting Influential Voices When you've got former NFL stars like Matt...

Continue Reading

Top 5 Most Recently Viewed Articles

Health Canada Greenlights Bylvay™ for Alagille Syndrome Relief

Updated Category News Views 132

Health Canada's Approval of Bylvay™ for Alagille Syndrome Bylvay™ is a groundbreaking medication that has recently received approval from Health Canada, becoming the first of its kind to treat both Alagille Syndrome and Progressive Familial Intrahepatic Cholestasis. This approval is particularly significant as it offers hope to patients aged 12 months and older who...

Continue Reading
Delta Airlines Faces Turbulence Amid Legal Challenges Ahead

Updated Category News Views 270

Delta Airlines Climbs in Pre-Market Trading Delta Air Lines, Inc. (NYSE: DAL) experienced a notable 2.61% increase in pre-market trading. This rise follows the airline's recent decision to take legal action against Crowdstrike Inc. (NASDAQ: CRWD), marking significant developments for both companies. Market Performance Overview Delta Airlines' stock was quoted at $55.34,...

Continue Reading
Warner Bros Discovery Gains Favor While Fox Corp Faces Downgrade

Updated Category News Views 103

Warner Bros Discovery Receives Upgraded Rating MoffettNathanson has recently made headlines by upgrading Warner Bros Discovery Inc (NASDAQ: WBD) from a 'Neutral' to a 'Buy' rating. This significant change in outlook is driven by enhancements in the company's financial stability, impressive growth at Max, and the alleviation of various studio challenges. Positive Financial...

Continue Reading
Allarity Therapeutics Doses Second Patient in Ovarian Cancer Trial

Updated Category News Views 109

Advancing Treatment Options with Stenoparib Allarity Therapeutics, Inc. (NASDAQ: ALLR), a prominent name in the biopharmaceutical industry, has set a significant milestone by dosing its second patient in a Phase 2 clinical trial. This trial aims to explore the efficacy of stenoparib, a dual PARP and WNT pathway inhibitor, for individuals battling advanced ovarian cancer...

Continue Reading
NOTÖRIOUS Unleashes Debut EP 'Live It Up' with Heavy Sound

Updated Category News Views 222

NOTÖRIOUS Launches 'Live It Up' with a Self-Titled EP With their new single "Live It Up" and a self-titled EP that carries their name with pride, NOTÖRIOUS proves that rock is far from being dormant. The group, renowned for their vibrant energy and explosive performances, is infusing glam metal with their distinctive sound. The Spirit of Glam Metal is Alive "Tonight's...

Continue Reading